These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5166217)

  • 21. Diphenylhydantoin intoxication. A complication of isoniazid therapy.
    Kutt H; Brennan R; Dehejia H; Verebely K
    Am Rev Respir Dis; 1970 Mar; 101(3):377-84. PubMed ID: 5414058
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of phenytoin and carbamazepine in treatment of epilepsy.
    Ramsay RE
    Neurol Clin; 1986 Aug; 4(3):585-600. PubMed ID: 2943977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of diphenylhydantoin disposition in man.
    Suzuki T; Saito Y; Nishihara K
    Chem Pharm Bull (Tokyo); 1970 Feb; 18(2):405-11. PubMed ID: 5438584
    [No Abstract]   [Full Text] [Related]  

  • 24. [Phenobarbital intoxication in a patient with primidone and diphenylhydantoin (author's transl)].
    Galdames D; Ortiz M; Saavedra I; Aguilera L
    Rev Med Chil; 1980 Aug; 108(8):716-20. PubMed ID: 7221259
    [No Abstract]   [Full Text] [Related]  

  • 25. Diphenylhydantoin dosage.
    Eadie MJ; Tyrer JH; Hooper WD
    Proc Aust Assoc Neurol; 1973; 10(0):53-9. PubMed ID: 4792162
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of diphenylhydantoin on hepatic drug hydroxylation.
    Petruch F; Schüppel RV; Steinhilber G
    Eur J Clin Pharmacol; 1974 Jul; 7(4):281-5. PubMed ID: 4851632
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial: Plasma diphenylhydantoin levels.
    Ourrier RA
    Aust N Z J Med; 1974 Oct; 4(5):524-6. PubMed ID: 4532924
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacodynamic aspects of phenobarbital (PB) and diphenylhydantoin (DPH). Correlations with clinical findings].
    Denegri M; Luciano L
    Rev Neuropsychiatr Infant; 1972; 20(3):375-83. PubMed ID: 5055027
    [No Abstract]   [Full Text] [Related]  

  • 29. The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.
    Svendsen TL; Kristensen MB; Hansen JM; Skovsted L
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):439-41. PubMed ID: 971708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma disappearance of transplacentally transferred diphenylhydantoin in the newborn studied by mass fragmentography.
    Rane A; Garle M; Borgå O; Sjöqvist F
    Clin Pharmacol Ther; 1974 Jan; 15(1):39-45. PubMed ID: 4808742
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of dosage increments on blood phenytoin concentrations.
    Bochner F; Hooper WD; Tyrer JH; Eadie MJ
    J Neurol Neurosurg Psychiatry; 1972 Dec; 35(6):873-6. PubMed ID: 4647859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenytoin elimination in childhood: effect of concentration-dependent kinetics.
    Dodson WE
    Neurology; 1980 Feb; 30(2):196-9. PubMed ID: 7188800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Removal of phenytoin by hemodialysis in uremic patients.
    Martin E; Gambertoglio JG; Adler DS; Tozer TN; Roman LA; Grausz H
    JAMA; 1977 Oct; 238(16):1750-3. PubMed ID: 578272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diphenylhydantoin intoxication attendant to slow inactivation of isoniazid.
    Brennan RW; Dehejia H; Kutt H; Verebely K; McDowell F
    Neurology; 1970 Jul; 20(7):687-93. PubMed ID: 5463537
    [No Abstract]   [Full Text] [Related]  

  • 35. Diphenylhydantoin.
    Glazko AJ
    Pharmacology; 1972; 8(1):163-77. PubMed ID: 4630160
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum copper levels and diphenylhydantoin.
    Taylor JD; Krahn PM; Higgins TN
    Am J Clin Pathol; 1974 Apr; 61(4):577-8. PubMed ID: 4816800
    [No Abstract]   [Full Text] [Related]  

  • 37. Altered protein binding of diphenylhydantoin in uremic plasma.
    Blum MR; Riegelman S; Becker CE
    N Engl J Med; 1972 Jan; 286(2):109. PubMed ID: 5006870
    [No Abstract]   [Full Text] [Related]  

  • 38. [Daily fluctuations of plasma diphenylhydantoin in patients treated with diphenylhydantoin and sodium valproate].
    Pisani F; Di Perri R
    Acta Neurol (Napoli); 1981 Feb; 3(1):61-3. PubMed ID: 6787844
    [No Abstract]   [Full Text] [Related]  

  • 39. Excretion of phenytoin into semen of rabbits and man. Comparison with plasma levels.
    Swanson BN; Leger RM; Gordon WP; Lynn RK; Gerber N
    Drug Metab Dispos; 1978; 6(1):70-4. PubMed ID: 23276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of stimulation of antipyrine and phenytoin metabolism by lithium carbonate in man.
    Perrild H; Hansen JM; Skovsted L; Simonsen K; Hegedüs L; Christensen LK
    Acta Pharmacol Toxicol (Copenh); 1983 Apr; 52(4):315-7. PubMed ID: 6408891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.